What are the cost differences between cannabis and traditional treatments of AS? 

For many patients weighing cannabis alternatives against conventional treatment, cost is a significant factor. Traditional options like NSAIDs and biologics are often covered by the NHS or private insurance, while medical cannabis remains an out-of-pocket expense in most cases. 

Prices for cannabis vary widely depending on product type, dosage, and source. Patients pursuing combined therapy using cannabis alongside standard medications may face added costs unless a clear benefit justifies the investment. In some cases, patient resistance to conventional treatments due to side effects or lack of relief leads them to explore these newer alternatives despite the financial burden. 

What to Consider About Costs 

Coverage and access 

Biologics and NSAIDs are often subsidised or fully covered. Medical cannabis is typically not. 

Upfront vs ongoing costs 

Cannabis requires regular purchases and follow-ups with private clinics, which adds up over time. 

Health vs financial trade-offs 

Some patients prioritise quality of life and symptom control over lower costs. 

Medical input is key 

Get rheumatologist advice when weighing cost against potential outcomes, especially with cannabis alternatives. 

Visit providers like LeafEase to understand the full financial picture and explore cost-effective paths to care using cannabis-based or traditional AS treatments. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.